Contineum Therapeutics, Inc.

Develops oral small molecule therapies for neurological, inflammatory, and fibrotic diseases.

CTNM | US

Overview

Corporate Details

ISIN(s):: US21217B1008
LEI:
Country:: United States of America
Address:: 3565 GENERAL ATOMICS COURT, SUITE 200, 92121 SAN DIEGO
Website:: https://www.contineum-tx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Contineum Therapeutics, Inc. is a clinical-stage biopharmaceutical company that discovers and develops novel, oral small molecule therapies. The company focuses on pioneering treatments for conditions at the intersection of neuroscience, inflammation, and immunology (NI&I). Its pipeline is based on clinically validated biological targets and includes a potential best-in-class LPA1R antagonist for idiopathic pulmonary fibrosis (IPF) and progressive multiple sclerosis (PrMS), and a potential first-in-class M1R antagonist for major depressive disorder (MDD) in collaboration with a Johnson & Johnson company. Formerly Pipeline Therapeutics, Contineum aims to develop impactful treatments for serious neurological, inflammatory, and fibrotic diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Contineum Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Contineum Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Contineum Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Eevia Health Plc Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.	Finland	EEVIA
Egetis Therapeutics Develops and commercializes drugs for serious rare diseases with unmet medical needs.	Sweden	EGTX
EIKEN CHEMICAL CO.,LTD. Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.	Japan	4549
Eisai Co., Ltd. A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.	Japan	4523
Elanco Animal Health Inc Develops medicines, vaccines, and services to treat and prevent disease in pets and farm animals.	United States of America	ELAN
Eledon Pharmaceuticals, Inc. Develops immunomodulatory therapies to prevent organ rejection in transplant patients.	United States of America	ELDN
Elicera Therapeutics AB Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.	Sweden	ELIC
ELI LILLY & Co Pharma leader developing medicines for diabetes, obesity, oncology, and neuroscience.	United States of America	LLY
Ellen AB Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.	Sweden	ELN
ELUTIA INC. Develops drug-eluting biologics to reduce complications from medical implants.	United States of America	ELUT